首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Biostatistics

缩写:BIOSTATISTICS

ISSN:1465-4644

e-ISSN:1468-4357

IF/分区:2.1/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1129
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Haiyan Zheng,James M S Wason Haiyan Zheng
Basket trials have emerged as a new class of efficient approaches in oncology to evaluate a new treatment in several patient subgroups simultaneously. In this article, we extend the key ideas to disease areas outside of oncology, developing...
Dimitra-Kleio Kipourou,Maja Pohar Perme,Bernard Rachet et al. Dimitra-Kleio Kipourou et al.
In population-based cancer studies, net survival is a crucial measure for population comparison purposes. However, alternative measures, namely the crude probability of death (CPr) and the number of life years lost (LYL) due to death accord...
Menghan Hu,Ciprian Crainiceanu,Matthew K Schindler et al. Menghan Hu et al.
Our main goal is to study and quantify the evolution of multiple sclerosis lesions observed longitudinally over many years in multi-sequence structural magnetic resonance imaging (sMRI). To achieve that, we propose a class of functional mod...
Denis Rustand,Laurent Briollais,Christophe Tournigand et al. Denis Rustand et al.
Joint models for a longitudinal biomarker and a terminal event have gained interests for evaluating cancer clinical trials because the tumor evolution reflects directly the state of the disease. A biomarker characterizing the tumor size evo...
Hyoyoung Choo-Wosoba,Paul S Albert,Bin Zhu Hyoyoung Choo-Wosoba
Allele-specific copy number alteration (ASCNA) analysis is for identifying copy number abnormalities in tumor cells. Unlike normal cells, tumor cells are heterogeneous as a combination of dominant and minor subclones with distinct copy numb...
Yanxun Xu,Daniel Scharfstein,Peter Müller et al. Yanxun Xu et al.
We develop a Bayesian nonparametric (BNP) approach to evaluate the causal effect of treatment in a randomized trial where a nonterminal event may be censored by a terminal event, but not vice versa (i.e., semi-competing risks). Based on the...
Ying Wu,Richard J Cook Ying Wu
We develop methods for assessing the predictive accuracy of a given event time model when the validation sample is comprised of case $K$ interval-censored data. An imputation-based, an inverse probability weighted (IPW), and an augmented in...
M D Mahsin,Rob Deardon,Patrick Brown M D Mahsin
Infectious disease models can be of great use for understanding the underlying mechanisms that influence the spread of diseases and predicting future disease progression. Modeling has been increasingly used to evaluate the potential impact ...
Haoyu Zhang,Ni Zhao,Thomas U Ahearn et al. Haoyu Zhang et al.
Cancers are routinely classified into subtypes according to various features, including histopathological characteristics and molecular markers. Previous genome-wide association studies have reported heterogeneous associations between loci ...
Dustin J Rabideau,Rui Wang Dustin J Rabideau
In a cluster randomized trial (CRT), groups of people are randomly assigned to different interventions. Existing parametric and semiparametric methods for CRTs rely on distributional assumptions or a large number of clusters to maintain nom...